Anakinra May Be Effective for Treatment of Acute Gout Flares
Researchers evaluated the efficacy and safety of anakinra for the treatment of acute gout flares.
Gout
Patients With Sleep Apnea Have Increased Gout Risk
Among OSA patients, risk for developing gout is highest 1 to 2 years after the index date.
Case Study: White Paste Found After Ankle Aspiration
A 53-year-old obese man with a history of diabetes and hypertension presents with migratory bilateral ankle pain that is worse on the left side.
Panel Issues Consensus Statement on Management of Gouty Arthritis of the Foot and Ankle
An expert panel evaluated 23 separate statements related to the etiology, diagnosis, and treatment of gout.
Failure to Meet Optimal Urate Levels Increases Mortality Risk in Gout
Patients with gout who did not reach a serum uric acid level below 6 mg/dL had a 2.4-fold increased risk for death.
Gout Outcomes Favorable With Nurse-Led Care
In a British study, nurse-led care emphasizing patient education and engagement significantly improved the proportion of gout sufferers who achieved target serum urate levels.
Allopurinol Dose Escalation for Gout Does Not Improve Mortality
Linked to small increase in mortality; at 2 years, 31% of dose escalators achieved serum urate goal.
Incident Gout Risk, Serum Urate, and Comorbidities: What Are the Links?
Ethnicity and hypertension have an association with incident gout that is not fully explained by differences in serum urate.
FDA warns that febuxostat may increase risk of heart-related mortality
Preliminary clinical trial results show more heart-related deaths occur in patients taking febuxostat compared to allopurinol.
DASH diet associated with lower risk of gout
The DASH diet could offer a dietary strategy that may help prevent gout and its comorbidities in high-risk patients with hyperuricemia.
Next post in Rheumatology Information Center
